Effect of Food on the Pharmacokinetic and Pharmacodynamic Profiles of Hetrombopag in Healthy Volunteers-Reference-Cited by-同舟云学术

Effect of Food on the Pharmacokinetic and Pharmacodynamic Profiles of Hetrombopag in Healthy Volunteers

Published:2020-12 Issue:12 Volume:42 Page:2280-2288
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Wang Zhenlei,Chen Xiaogang,Li Aiwei,Chen Li,Wang Yongsheng,Zheng Li

Funder

Jiangsu HengRui Medicine Co., Ltd.

Major Specific Project of Sichuan Province of China

National Natural Science Foundation of China

Ministry of Science and Technology

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference26 articles.

1. Thrombopoietin receptor agonists: eltrombopag and romiplostim for the treatment of chronic immune thrombocytopenia purpura;Atkinson;Clin J Oncol Nurs,2019

2. Eltrombopag in immune thrombocytopenia, aplastic anemia, and myelodysplastic syndrome: from megakaryopoiesis to immunomodulation;Fattizzo;Drugs,2019

3. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura;Portielje;Blood,2001

4. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura;Bussel;N Engl J Med,2007

5. Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers;Harker;Blood,2000

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Hetrombopag for Thrombocytopenia in Patients with Advanced Solid Tumors: A Retrospective Study;Journal of Clinical Pharmacy and Therapeutics;2023-12-30

2. Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittently;Frontiers in Cardiovascular Medicine;2023-12-14

3. A phase I, single‐sequence, open‐label study to evaluate the drug–drug interaction between hetrombopag and cyclosporine in healthy Chinese subjects;British Journal of Clinical Pharmacology;2023-02-20

4. Novel Therapies to Address Unmet Needs in ITP;Pharmaceuticals;2022-06-23

5. Safety and efficacy of hetrombopag in patients with chronic immune thrombocytopenia: a single-arm, open-label, multi-center phase 1 study;Annals of Translational Medicine;2022-01